A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma

Blood Cancer Discovery · Published 2026-06-24 · DOI 10.1158/2643-3230.bcd-26-0005

Free full text

Authors (27)

Haopeng Yang, Kotaro Arita, Kevin Bowman, Dai Chihara, Jared Henderson, Griffin Rost, Estela Rojas, Sydney Parsons, Priya Lakra, Aneela Syeda Abedin, Sattva Neelapu, Paolo Strati, Loretta J. Nastoupil, Luis E. Fayad, Swaminathan P. Iyer, Alma Rodriguez, Fredrick B. Hagemeister, Luis Malpica, Hun Lee, Laura K. Hilton, David W. Scott, R. Eric Davis, Christopher R Flowers, Jason Westin, Giorgio Inghirami, Francisco Vega, Michael R. Green

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, H., Arita, K., Bowman, K., et al. (2026). A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-26-0005

Related articles

• Improving Knowledge and Care of Patients with AML: The Need to Get Out of Our Comfort Zone · Blood Cancer Discovery · 2026 · Same journal
• MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1 -Mutant Leukemia · Blood Cancer Discovery · 2026 · Same journal
• Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry · Blood Cancer Discovery · 2026 · Same journal
• LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models · Blood Cancer Discovery · 2026 · Same journal
• Rewiring the Leukemic Genome: 3D Chromatin Architecture in B-cell Acute Lymphoblastic Leukemia · Blood Cancer Discovery · 2026 · Same journal
• The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells · Blood Cancer Discovery · 2026 · Same journal
• Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid Malignancies · Blood Cancer Discovery · 2026 · Same journal
• Highlighted Research Articles · Blood Cancer Discovery · 2026 · Same journal
• Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma · Blood Cancer Discovery · 2026 · Same journal
• Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial · Blood Cancer Discovery · 2026 · Same journal